Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
12
pubmed:dateCreated
2010-3-24
pubmed:abstractText
Application of nanotechnology to medical biology has brought remarkable success. Water-soluble fullerenes are molecules with great potential for biological use because they can endow unique characteristics of amphipathic property and form a self-assembled structure by chemical modification. Effective gene delivery in vitro with tetra(piperazino)fullerene epoxide (TPFE) and its superiority to Lipofectin have been described in a previous report. For this study, we evaluated the efficacy of in vivo gene delivery by TPFE. Delivery of enhanced green fluorescent protein gene (EGFP) by TPFE on pregnant female ICR mice showed distinct organ selectivity compared with Lipofectin; moreover, higher gene expression by TPFE was found in liver and spleen, but not in the lung. No acute toxicity of TPFE was found for the liver and kidney, although Lipofectin significantly increased liver enzymes and blood urea nitrogen. In fetal tissues, neither TPFE nor Lipofectin induced EGFP gene expression. Delivery of insulin 2 gene to female C57/BL6 mice increased plasma insulin levels and reduced blood glucose concentrations, indicating the potential of TPFE-based gene delivery for clinical application. In conclusion, this study demonstrated effective gene delivery in vivo for the first time using a water-soluble fullerene.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/20194788-10329392, http://linkedlifedata.com/resource/pubmed/commentcorrection/20194788-10428213, http://linkedlifedata.com/resource/pubmed/commentcorrection/20194788-10637451, http://linkedlifedata.com/resource/pubmed/commentcorrection/20194788-10830716, http://linkedlifedata.com/resource/pubmed/commentcorrection/20194788-10873662, http://linkedlifedata.com/resource/pubmed/commentcorrection/20194788-10888302, http://linkedlifedata.com/resource/pubmed/commentcorrection/20194788-12407425, http://linkedlifedata.com/resource/pubmed/commentcorrection/20194788-1454808, http://linkedlifedata.com/resource/pubmed/commentcorrection/20194788-14622027, http://linkedlifedata.com/resource/pubmed/commentcorrection/20194788-17441052, http://linkedlifedata.com/resource/pubmed/commentcorrection/20194788-17630811, http://linkedlifedata.com/resource/pubmed/commentcorrection/20194788-17878152, http://linkedlifedata.com/resource/pubmed/commentcorrection/20194788-18360029, http://linkedlifedata.com/resource/pubmed/commentcorrection/20194788-19053809, http://linkedlifedata.com/resource/pubmed/commentcorrection/20194788-2463491, http://linkedlifedata.com/resource/pubmed/commentcorrection/20194788-2823261, http://linkedlifedata.com/resource/pubmed/commentcorrection/20194788-7611427, http://linkedlifedata.com/resource/pubmed/commentcorrection/20194788-7773286, http://linkedlifedata.com/resource/pubmed/commentcorrection/20194788-8546385, http://linkedlifedata.com/resource/pubmed/commentcorrection/20194788-9035144, http://linkedlifedata.com/resource/pubmed/commentcorrection/20194788-9135736, http://linkedlifedata.com/resource/pubmed/commentcorrection/20194788-9210191, http://linkedlifedata.com/resource/pubmed/commentcorrection/20194788-9322091, http://linkedlifedata.com/resource/pubmed/commentcorrection/20194788-9349425, http://linkedlifedata.com/resource/pubmed/commentcorrection/20194788-9349432, http://linkedlifedata.com/resource/pubmed/commentcorrection/20194788-9371426, http://linkedlifedata.com/resource/pubmed/commentcorrection/20194788-9884331
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Mar
pubmed:issn
1091-6490
pubmed:author
pubmed:issnType
Electronic
pubmed:day
23
pubmed:volume
107
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
5339-44
pubmed:dateRevised
2011-11-17
pubmed:meshHeading
pubmed-meshheading:20194788-Animals, pubmed-meshheading:20194788-Base Sequence, pubmed-meshheading:20194788-DNA, Recombinant, pubmed-meshheading:20194788-DNA Primers, pubmed-meshheading:20194788-Female, pubmed-meshheading:20194788-Fetus, pubmed-meshheading:20194788-Fullerenes, pubmed-meshheading:20194788-Gene Expression, pubmed-meshheading:20194788-Gene Therapy, pubmed-meshheading:20194788-Gene Transfer Techniques, pubmed-meshheading:20194788-Green Fluorescent Proteins, pubmed-meshheading:20194788-Insulin, pubmed-meshheading:20194788-Mice, pubmed-meshheading:20194788-Mice, Inbred C57BL, pubmed-meshheading:20194788-Mice, Inbred ICR, pubmed-meshheading:20194788-Nanotechnology, pubmed-meshheading:20194788-Phosphatidylethanolamines, pubmed-meshheading:20194788-Pregnancy, pubmed-meshheading:20194788-Recombinant Proteins, pubmed-meshheading:20194788-Solubility, pubmed-meshheading:20194788-Tissue Distribution, pubmed-meshheading:20194788-Water
pubmed:year
2010
pubmed:articleTitle
In vivo gene delivery by cationic tetraamino fullerene.
pubmed:affiliation
Department of Chemistry and Exploratory Research for Advanced Technology (Japan Science and Technology Agency), University of Tokyo, 7-3-1 Hongo Bunkyo, Tokyo 113-0033, Japan.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't, Evaluation Studies